PL3003330T3 - Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzania - Google Patents
Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzaniaInfo
- Publication number
- PL3003330T3 PL3003330T3 PL14742388T PL14742388T PL3003330T3 PL 3003330 T3 PL3003330 T3 PL 3003330T3 PL 14742388 T PL14742388 T PL 14742388T PL 14742388 T PL14742388 T PL 14742388T PL 3003330 T3 PL3003330 T3 PL 3003330T3
- Authority
- PL
- Poland
- Prior art keywords
- mrt
- compositions
- manufacture
- methods
- restoration therapy
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/37—Digestive system
- A61K35/38—Stomach; Intestine; Goblet cells; Oral mucosa; Saliva
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0278—Physical preservation processes
- A01N1/0284—Temperature processes, i.e. using a designated change in temperature over time
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B25/00—Packaging other articles presenting special problems
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B65—CONVEYING; PACKING; STORING; HANDLING THIN OR FILAMENTARY MATERIAL
- B65B—MACHINES, APPARATUS OR DEVICES FOR, OR METHODS OF, PACKAGING ARTICLES OR MATERIALS; UNPACKING
- B65B7/00—Closing containers or receptacles after filling
- B65B7/02—Closing containers or receptacles deformed by, or taking-up shape, of, contents, e.g. bags, sacks
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving viable microorganisms
- C12Q1/04—Determining presence or kind of microorganism; Use of selective media for testing antibiotics or bacteriocides; Compositions containing a chemical indicator therefor
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Virology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Dentistry (AREA)
- Environmental Sciences (AREA)
- Developmental Biology & Embryology (AREA)
- Mechanical Engineering (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Analytical Chemistry (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361831409P | 2013-06-05 | 2013-06-05 | |
PCT/US2014/040856 WO2014197562A1 (en) | 2013-06-05 | 2014-06-04 | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
EP14742388.3A EP3003330B1 (en) | 2013-06-05 | 2014-06-04 | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
Publications (2)
Publication Number | Publication Date |
---|---|
PL3003330T4 PL3003330T4 (pl) | 2019-03-29 |
PL3003330T3 true PL3003330T3 (pl) | 2019-03-29 |
Family
ID=51220860
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL14742388T PL3003330T3 (pl) | 2013-06-05 | 2014-06-04 | Terapia przywracająca mikrobiota (MRT), kompozycje i sposoby wytwarzania |
Country Status (17)
Country | Link |
---|---|
US (12) | US9675648B2 (pl) |
EP (3) | EP3375447A1 (pl) |
JP (2) | JP6330032B2 (pl) |
KR (3) | KR102291174B1 (pl) |
CN (2) | CN114099553A (pl) |
AU (5) | AU2014275025B2 (pl) |
CA (1) | CA2914636C (pl) |
DK (1) | DK3003330T3 (pl) |
ES (1) | ES2673581T3 (pl) |
HR (1) | HRP20181302T1 (pl) |
HU (1) | HUE040211T2 (pl) |
IL (2) | IL242934B (pl) |
LT (1) | LT3003330T (pl) |
PL (1) | PL3003330T3 (pl) |
PT (1) | PT3003330T (pl) |
SI (1) | SI3003330T1 (pl) |
WO (1) | WO2014197562A1 (pl) |
Families Citing this family (145)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
HRP20220751T1 (hr) | 2010-02-01 | 2022-09-02 | Rebiotix, Inc. | Bakterioterapija clostridium difficile kolitisa |
SG187713A1 (en) | 2010-08-04 | 2013-03-28 | Borody Thomas J | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
HK1253538A1 (zh) * | 2010-08-04 | 2019-06-21 | Borody Thomas J | 用於糞便菌群植入的組合物及其製備和使用方法 |
US9987224B2 (en) | 2011-02-04 | 2018-06-05 | Joseph E. Kovarik | Method and system for preventing migraine headaches, cluster headaches and dizziness |
US11273187B2 (en) | 2015-11-30 | 2022-03-15 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing depression in an individual |
US11191665B2 (en) | 2011-02-04 | 2021-12-07 | Joseph E. Kovarik | Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being |
US10085938B2 (en) | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for preventing sore throat in humans |
US10583033B2 (en) | 2011-02-04 | 2020-03-10 | Katherine Rose Kovarik | Method and system for reducing the likelihood of a porphyromonas gingivalis infection in a human being |
US10010568B2 (en) | 2011-02-04 | 2018-07-03 | Katherine Rose Kovarik | Method and system for reducing the likelihood of a spirochetes infection in a human being |
US10548761B2 (en) | 2011-02-04 | 2020-02-04 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
US11419903B2 (en) | 2015-11-30 | 2022-08-23 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US10842834B2 (en) | 2016-01-06 | 2020-11-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
US10835560B2 (en) | 2013-12-20 | 2020-11-17 | Joseph E. Kovarik | Reducing the likelihood of skin cancer in an individual human being |
US10111913B2 (en) | 2011-02-04 | 2018-10-30 | Joseph E. Kovarik | Method of reducing the likelihood of skin cancer in an individual human being |
US11357722B2 (en) | 2011-02-04 | 2022-06-14 | Seed Health, Inc. | Method and system for preventing sore throat in humans |
US10086018B2 (en) | 2011-02-04 | 2018-10-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of colorectal cancer in a human being |
US11998479B2 (en) | 2011-02-04 | 2024-06-04 | Seed Health, Inc. | Method and system for addressing adverse effects on the oral microbiome and restoring gingival health caused by sodium lauryl sulphate exposure |
US11951139B2 (en) | 2015-11-30 | 2024-04-09 | Seed Health, Inc. | Method and system for reducing the likelihood of osteoporosis |
US11951140B2 (en) | 2011-02-04 | 2024-04-09 | Seed Health, Inc. | Modulation of an individual's gut microbiome to address osteoporosis and bone disease |
US10512661B2 (en) | 2011-02-04 | 2019-12-24 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing liver cancer in an individual diagnosed with non-alcoholic fatty liver disease |
US10687975B2 (en) | 2011-02-04 | 2020-06-23 | Joseph E. Kovarik | Method and system to facilitate the growth of desired bacteria in a human's mouth |
US11523934B2 (en) | 2011-02-04 | 2022-12-13 | Seed Health, Inc. | Method and system to facilitate the growth of desired bacteria in a human's mouth |
US10245288B2 (en) | 2011-02-04 | 2019-04-02 | Joseph E. Kovarik | Method and system for reducing the likelihood of developing NASH in an individual diagnosed with non-alcoholic fatty liver disease |
US11844720B2 (en) | 2011-02-04 | 2023-12-19 | Seed Health, Inc. | Method and system to reduce the likelihood of dental caries and halitosis |
ES2636439T3 (es) | 2011-03-09 | 2017-10-05 | Regents Of The University Of Minnesota | Composiciones y métodos para el trasplante de microbiota de colon |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
CA2914636C (en) | 2013-06-05 | 2021-04-06 | Rebiotix, Inc. | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
US11839632B2 (en) | 2013-12-20 | 2023-12-12 | Seed Health, Inc. | Topical application of CRISPR-modified bacteria to treat acne vulgaris |
US11980643B2 (en) | 2013-12-20 | 2024-05-14 | Seed Health, Inc. | Method and system to modify an individual's gut-brain axis to provide neurocognitive protection |
US11833177B2 (en) | 2013-12-20 | 2023-12-05 | Seed Health, Inc. | Probiotic to enhance an individual's skin microbiome |
US11969445B2 (en) | 2013-12-20 | 2024-04-30 | Seed Health, Inc. | Probiotic composition and method for controlling excess weight, obesity, NAFLD and NASH |
US12005085B2 (en) | 2013-12-20 | 2024-06-11 | Seed Health, Inc. | Probiotic method and composition for maintaining a healthy vaginal microbiome |
US11826388B2 (en) | 2013-12-20 | 2023-11-28 | Seed Health, Inc. | Topical application of Lactobacillus crispatus to ameliorate barrier damage and inflammation |
US11998574B2 (en) | 2013-12-20 | 2024-06-04 | Seed Health, Inc. | Method and system for modulating an individual's skin microbiome |
US10366793B2 (en) | 2014-10-21 | 2019-07-30 | uBiome, Inc. | Method and system for characterizing microorganism-related conditions |
US10793907B2 (en) | 2014-10-21 | 2020-10-06 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions |
US11783914B2 (en) | 2014-10-21 | 2023-10-10 | Psomagen, Inc. | Method and system for panel characterizations |
US10346592B2 (en) | 2014-10-21 | 2019-07-09 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
US10325685B2 (en) | 2014-10-21 | 2019-06-18 | uBiome, Inc. | Method and system for characterizing diet-related conditions |
US10410749B2 (en) | 2014-10-21 | 2019-09-10 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cutaneous conditions |
US10388407B2 (en) | 2014-10-21 | 2019-08-20 | uBiome, Inc. | Method and system for characterizing a headache-related condition |
US10777320B2 (en) | 2014-10-21 | 2020-09-15 | Psomagen, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for mental health associated conditions |
US9710606B2 (en) | 2014-10-21 | 2017-07-18 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for neurological health issues |
US9754080B2 (en) | 2014-10-21 | 2017-09-05 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for cardiovascular disease conditions |
US10409955B2 (en) | 2014-10-21 | 2019-09-10 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for locomotor system conditions |
US10311973B2 (en) | 2014-10-21 | 2019-06-04 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions |
US10789334B2 (en) | 2014-10-21 | 2020-09-29 | Psomagen, Inc. | Method and system for microbial pharmacogenomics |
US10395777B2 (en) | 2014-10-21 | 2019-08-27 | uBiome, Inc. | Method and system for characterizing microorganism-associated sleep-related conditions |
US9760676B2 (en) | 2014-10-21 | 2017-09-12 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for endocrine system conditions |
US10357157B2 (en) | 2014-10-21 | 2019-07-23 | uBiome, Inc. | Method and system for microbiome-derived characterization, diagnostics and therapeutics for conditions associated with functional features |
US10381112B2 (en) | 2014-10-21 | 2019-08-13 | uBiome, Inc. | Method and system for characterizing allergy-related conditions associated with microorganisms |
EP3209803A4 (en) | 2014-10-21 | 2018-06-13 | Ubiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics |
US10265009B2 (en) | 2014-10-21 | 2019-04-23 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome taxonomic features |
US10169541B2 (en) | 2014-10-21 | 2019-01-01 | uBiome, Inc. | Method and systems for characterizing skin related conditions |
US9758839B2 (en) | 2014-10-21 | 2017-09-12 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for conditions associated with microbiome functional features |
US10073952B2 (en) | 2014-10-21 | 2018-09-11 | uBiome, Inc. | Method and system for microbiome-derived diagnostics and therapeutics for autoimmune system conditions |
GB201421735D0 (en) * | 2014-12-07 | 2015-01-21 | Craig Nicola M | Humanized gut microbiota |
LT3065748T (lt) | 2014-12-23 | 2018-03-12 | 4D Pharma Research Limited | Bacteroides thetaiotaomicron padermė ir jos panaudojimas uždegimo sumažinimui |
HUE037476T2 (hu) | 2014-12-23 | 2018-08-28 | 4D Pharma Res Ltd | Pirin polipeptid és immunmodulálás |
US10246753B2 (en) | 2015-04-13 | 2019-04-02 | uBiome, Inc. | Method and system for characterizing mouth-associated conditions |
CA3021690A1 (en) | 2015-04-20 | 2016-10-27 | S-Biomedic Nv | Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains |
FR3035328B1 (fr) * | 2015-04-24 | 2019-08-23 | Maat Pharma | Procede de preparation d'un echantillon de microbiote fecal |
FR3035317B1 (fr) | 2015-04-24 | 2019-06-14 | Maat Pharma | Dispositif de prelevement de micro-organismes, kit de prelevement comprenant un tel dispositif et procede de prelevement mettant en œuvre un tel dispositif |
WO2016178775A1 (en) * | 2015-05-01 | 2016-11-10 | Microbiome Health Research Institute Inc. | Compositions and methods for therapeutic delivery of microbial communities |
AU2016202831B2 (en) * | 2015-05-08 | 2021-11-18 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
WO2016181228A2 (en) | 2015-05-11 | 2016-11-17 | Mybiotix Pharma Ltd. | Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut |
DK3297644T3 (da) * | 2015-05-22 | 2022-04-11 | Univ Arizona State | Fremgangsmåder til behandling af autismespektrumforstyrrelse og forbundne symptomer |
IL281424B2 (en) | 2015-06-09 | 2023-10-01 | Rebiotix Inc | Microbiota restoration treatment preparations and production methods |
US10905726B2 (en) * | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
LT3650033T (lt) | 2015-06-15 | 2022-04-11 | 4D Pharma Research Limited | Kompozicijos, apimančios bakterinius kamienus |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3636272A1 (en) | 2015-06-15 | 2020-04-15 | 4D Pharma Research Limited | Compositions comprising bacterial strains |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
RS59308B1 (sr) | 2015-06-15 | 2019-10-31 | 4D Pharma Res Ltd | Kompozicije koje sadrže bakterijske sojeve |
WO2017044827A1 (en) | 2015-09-10 | 2017-03-16 | Life Technologies Corporation | Purification of nucleic acid from environmental or biological samples |
CN105219645B (zh) * | 2015-11-06 | 2018-09-25 | 南京农业大学 | 一种微生物保护剂及其应用 |
GB2561748B (en) | 2015-11-20 | 2019-05-08 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
US10675347B2 (en) | 2015-11-30 | 2020-06-09 | Joseph E. Kovarik | Method and system for protecting honey bees from fipronil pesticides |
US10933128B2 (en) | 2015-11-30 | 2021-03-02 | Joseph E. Kovarik | Method and system for protecting honey bees from pesticides |
US11529412B2 (en) | 2015-11-30 | 2022-12-20 | Seed Health, Inc. | Method and system for protecting honey bees from pesticides |
US10086024B2 (en) | 2015-11-30 | 2018-10-02 | Joseph E. Kovarik | Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides |
US10568916B2 (en) | 2015-11-30 | 2020-02-25 | Joseph E. Kovarik | Method and system for protecting honey bees, bats and butterflies from neonicotinoid pesticides |
FR3045383B1 (fr) | 2015-12-18 | 2019-06-14 | Maat Pharma | Procede de lyophilisation d'un echantillon de microbiote fecal |
WO2017137848A1 (en) * | 2016-02-11 | 2017-08-17 | Nubiyota, Llc | Systems and methods for characterizing compositions comprising fecal-derived bacterial populations |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
TW201733601A (zh) | 2016-03-04 | 2017-10-01 | 4D製藥有限公司 | 包含細菌菌株之組合物 |
EP3455373A1 (en) | 2016-05-13 | 2019-03-20 | Rebiotix, Inc. | Analytical method for quanitification of viable bacteria contained in microbiota restoration therapy (mrt) compositions |
RU2018141320A (ru) * | 2016-05-25 | 2020-06-25 | Майбиотикс Фарма Лтд. | Композиция и способы для микробиотной терапии |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
TWI802545B (zh) | 2016-07-13 | 2023-05-21 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
US20180036352A1 (en) * | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
WO2018071532A1 (en) * | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating chronic fatigue syndrome and related disorders |
US20210275603A1 (en) * | 2016-10-11 | 2021-09-09 | Crestovo Holdings Llc | Compositions and Methods for Treating Irritable Bowel Syndrome and Related Disorders |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018071537A1 (en) * | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
PL3912630T3 (pl) | 2016-10-19 | 2024-04-15 | S-Biomedic Nv | Sposoby i kompozycje do zmiany składu mikrobiomu skóry z wykorzystaniem złożonych mieszanek szczepów bakteryjnych |
CN110267669A (zh) * | 2016-12-06 | 2019-09-20 | 潘德勒姆治疗公司 | 与分离并纯化的微生物有关的方法和组合物 |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
WO2018129249A1 (en) * | 2017-01-05 | 2018-07-12 | The University Of Chicago | Inhibition of enteric infection through the modulation of microbiota |
EP3570855A1 (en) * | 2017-01-19 | 2019-11-27 | Pleonova AB | Autologous fecal sample for use in the treatment of microbial dysbiosis |
WO2018155614A1 (ja) * | 2017-02-23 | 2018-08-30 | 大塚テクノ株式会社 | 腸内細菌叢抽出容器 |
DE102017203234B4 (de) | 2017-02-28 | 2018-11-15 | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. | Mikrobiom-Transplantation |
CA3058943C (en) | 2017-04-03 | 2023-10-17 | Gusto Global, Llc | Rational design of microbial-based biotherapeutics |
CN110831606A (zh) * | 2017-04-05 | 2020-02-21 | 克雷斯顿沃控股公司 | 治疗帕金森氏病(pd)和相关疾病的组合物和方法 |
US11040073B2 (en) | 2017-04-05 | 2021-06-22 | Finch Therapeutics Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
MA48940A (fr) | 2017-05-22 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3630942B1 (en) | 2017-05-24 | 2022-11-30 | 4D Pharma Research Limited | Compositions comprising bacterial strain |
WO2018218159A1 (en) | 2017-05-26 | 2018-11-29 | Crestovo Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
MD3638271T2 (ro) | 2017-06-14 | 2021-03-31 | 4D Pharma Res Ltd | Compoziții cuprizând tulpini bacteriene |
DK3804737T3 (da) | 2017-06-14 | 2022-07-25 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
AU2018313766A1 (en) | 2017-08-07 | 2020-02-20 | Finch Therapeutics, Inc. | Compositions and methods for maintaining and restoring a healthy gut barrier |
US20200360450A1 (en) * | 2017-08-07 | 2020-11-19 | Finch Therapeutics, Inc. | Treatment of liver disease by modulation of the microbiome |
CN111328331A (zh) * | 2017-08-07 | 2020-06-23 | 芬奇治疗公司 | 用于将肠道中的抗生素抗性细菌去定植的组合物和方法 |
EP3443967A1 (de) * | 2017-08-17 | 2019-02-20 | Labor L + S Aktiengesellschaft | Verfahren zur einlagerung der bakterienflora des darms eines lebewesens, insbesondere eines menschen |
WO2019075426A1 (en) | 2017-10-13 | 2019-04-18 | Rebiotix, Inc. | MICROBIOM HEALTH INDEX |
FR3078627B1 (fr) | 2018-03-09 | 2020-11-13 | Maat Pharma | Procedure de collecte de selles et procede de preparation d'un echantillon pour transplantation de microbiote fecal |
WO2019213595A1 (en) | 2018-05-04 | 2019-11-07 | Ferring B.V. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
EP3806874A1 (en) | 2018-06-14 | 2021-04-21 | Rebiotix, Inc. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
US20210283197A1 (en) | 2018-07-17 | 2021-09-16 | Ferring B.V. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
WO2020069280A1 (en) | 2018-09-27 | 2020-04-02 | Crestovo Holdings Llc | Compositions and methods for treating epilepsy and related disorders |
WO2020086413A1 (en) * | 2018-10-26 | 2020-04-30 | Locus Oil Ip Company, Llc | Personalized system for restoring the gastrointestinal tract microbiome |
US10709744B1 (en) | 2019-03-28 | 2020-07-14 | Mybiotics Pharma Ltd. | Probiotic biofilm suppositories |
CN113950248A (zh) | 2019-04-12 | 2022-01-18 | 轨迹Ip有限责任公司 | 用于增强碳封存和减少牲畜产生的温室气体排放物的牧场处理 |
KR20220038698A (ko) | 2019-07-31 | 2022-03-29 | 디그 랩스 코퍼레이션 | 동물 건강 평가 |
US11763920B2 (en) | 2019-07-31 | 2023-09-19 | Dig Labs Corporation | Mucus analysis for animal health assessments |
WO2021096794A1 (en) * | 2019-11-11 | 2021-05-20 | Hazan Sabine | Method of treating an individual with a health condition with fecal microbiota transplant |
KR102296880B1 (ko) * | 2019-12-04 | 2021-09-02 | 주식회사 쓰임받는사람들 | 입체 그림물감 |
EP3838269A1 (en) | 2019-12-16 | 2021-06-23 | European Molecular Biology Laboratory | Compounds and pharmaceutical compositions for prevention and/or treatment of dysbiosis and antibacterial antidotes for microbiome-protection |
WO2021130181A1 (en) * | 2019-12-23 | 2021-07-01 | Lauridsen Hengameh Chloe | Novel faecal composition |
EP4081189A1 (en) * | 2019-12-23 | 2022-11-02 | Hengameh Chloe Lauridsen | Capsule comprising a faecal composition |
US11744866B2 (en) | 2020-03-18 | 2023-09-05 | Sabine Hazan | Methods of preventing and treating COVID-19 infection with probiotics |
CN111534466B (zh) * | 2020-05-14 | 2021-06-04 | 深圳市融思生物科技有限公司 | 一种人类粪便肠道菌群样本的处理方法及处理试剂 |
JP2023527876A (ja) | 2020-06-01 | 2023-06-30 | フェリング ベスローテン フェンノートシャップ | 膣内微生物叢組成物 |
AU2021325955A1 (en) | 2020-08-14 | 2023-03-02 | Prolacta Bioscience, Inc. | Human milk oligosaccharide compositions for use with bacteriotherapies |
WO2022051610A1 (en) | 2020-09-04 | 2022-03-10 | Ferring B.V. | Microbiota restoration therapy (mrt) compositions and methods of manufacture |
WO2024006500A1 (en) * | 2022-07-01 | 2024-01-04 | Patternag, Inc. | Compositions and methods for stabilizing biological materials |
Family Cites Families (122)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL257275A (pl) | 1959-10-26 | |||
US3261761A (en) * | 1962-05-07 | 1966-07-19 | Arthur W Anderson | Method of freeze drying bacterial cultures |
EP0439453B1 (en) | 1987-10-12 | 1994-01-19 | Exomed Australia Pty. Ltd. (ACN 051 976 446) | Improved method for treatment of gastrointestinal disorders |
WO1989005659A1 (en) | 1987-12-24 | 1989-06-29 | Borody Thomas J | Orthostatic lavage solutions |
US5443826A (en) | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
DE68928665T2 (de) | 1988-08-02 | 1998-11-12 | Gastro Services Pty Ltd | Behandlung von gastro-intestinalen krankheiten |
CA1337265C (en) | 1988-08-04 | 1995-10-10 | Thomas Julius Borody | Oral antibody therapy for patients with lowered immune response and composition therefor |
CA2051092C (en) | 1990-09-12 | 2002-07-23 | Stephen A. Livesey | Method and apparatus for cryopreparation, dry stabilization and rehydration of biological suspensions |
JP3425441B2 (ja) | 1990-10-22 | 2003-07-14 | ガストロ サービシイズ ピーティーワイ リミテッド | 非炎症性及び非感染性腸障害の処置 |
US5519014A (en) | 1990-10-22 | 1996-05-21 | Borody; Thomas J. | Treatment of non-inflammatory and non-infectious bowel disorders |
US5229374A (en) | 1992-01-28 | 1993-07-20 | Burton Albert F | Method for treatment of lower gastrointestinal tract disorders |
JPH05292943A (ja) * | 1992-04-23 | 1993-11-09 | Nakano Vinegar Co Ltd | 微生物の保存方法 |
JP3025931B2 (ja) | 1993-07-07 | 2000-03-27 | 大塚製薬株式会社 | 表皮細胞シートの凍結保存用液 |
US5599795A (en) | 1994-08-19 | 1997-02-04 | Mccann; Michael | Method for treatment of idiopathic inflammatory bowel disease (IIBD) |
AUPM864894A0 (en) | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
US5656283A (en) | 1995-06-08 | 1997-08-12 | Ortho Pharmaceutical Corporation | In-situ lyophilization of vaginal suppository in unit dose applicator and resultant product |
EP0952773B1 (en) | 1995-09-15 | 2005-11-23 | Dale N. Gerding | Methods and compositions for prevention and treatment of clostridium difficile-associated diseases |
US6103268A (en) | 1995-11-03 | 2000-08-15 | Borody; Thomas Julius | Administering osmotic colonic evacuant containing a picosulfate |
AUPN634595A0 (en) | 1995-11-03 | 1995-11-30 | Borody, Thomas Julius | Improved method for colonic evacuation |
US5925354A (en) | 1995-11-30 | 1999-07-20 | Michigan State University | Riboflavin mutants as vaccines against Actinobacillus pleuropneumoniae |
US5711446A (en) | 1996-01-16 | 1998-01-27 | Sorenson Bioscience, Inc. | Cryogenic freezing vial |
US5902578A (en) | 1996-03-25 | 1999-05-11 | Abbott Laboratories | Method and formula for the prevention of diarrhea |
US5837238A (en) | 1996-06-05 | 1998-11-17 | Biogaia Biologics Ab | Treatment of diarrhea |
US6096310A (en) | 1997-04-15 | 2000-08-01 | Bier; Milan | Oral immunotherapy of bacterial overgrowth |
AUPO665397A0 (en) | 1997-05-07 | 1997-05-29 | Borody, Thomas Julius | Novel therapy for constipation |
US6969520B2 (en) | 1997-10-20 | 2005-11-29 | Acambis Inc. | Active immunization against clostridium difficile disease |
WO1999020304A1 (en) | 1997-10-20 | 1999-04-29 | Oravax, Inc. | Passive immunization against clostridium difficile disease |
US6179822B1 (en) * | 1998-01-20 | 2001-01-30 | Bracco Research Usa | Single use universal access device/medical container assembly |
US6179823B1 (en) * | 1998-01-20 | 2001-01-30 | Bracco Research Usa | Multiple use universal connector flexible medical container assembly |
US6428783B1 (en) | 1998-03-11 | 2002-08-06 | Medtech Center, Inc. | Bank of autochthonous strains of microorganisms and methods of its use for recovery of intestinal microbiocenosis of the men |
US6461607B1 (en) | 1998-08-24 | 2002-10-08 | Ganeden Biotech, Inc. | Probiotic, lactic acid-producing bacteria and uses thereof |
US6395467B1 (en) * | 1998-09-21 | 2002-05-28 | Gregory M. Fahy | Cryoprotectant solution containing dimethyl sulfoxide, an amide and ethylene glycol |
ID29150A (id) | 1999-01-15 | 2001-08-02 | Entpr Ireland Cs | Penggunaan lactobacillus salivarius |
US7430478B2 (en) | 2000-03-01 | 2008-09-30 | Caridian Bct, Inc. | Blood processing information system with blood loss equivalency tracking |
FR2808689B1 (fr) | 2000-05-11 | 2004-09-03 | Agronomique Inst Nat Rech | Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs |
JP2001327280A (ja) * | 2000-05-23 | 2001-11-27 | Lion Corp | 菌用凍結保存液 |
US20040170617A1 (en) | 2000-06-05 | 2004-09-02 | Finegold Sydney M. | Method of treating diseases associated with abnormal gastrointestinal flora |
US20040062757A1 (en) | 2001-06-05 | 2004-04-01 | Finegold Sydney M. | Method of testing gastrointestinal diseases associated with species of genus clostridium |
US20020013270A1 (en) | 2000-06-05 | 2002-01-31 | Bolte Ellen R. | Method for treating a mental disorder |
WO2001097821A1 (en) | 2000-06-19 | 2001-12-27 | Mucoprotec Pty Ltd | Immunotherapy or treating bacterial or viral infection at mucosal surfaces with probiotics, and compositions therefor. |
AU2001272369A1 (en) | 2000-07-17 | 2002-01-30 | Chr. Hansen A/S | Methods and formultations with probiotic microorganisms and medicaments |
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
AU2002902A (en) | 2000-11-14 | 2002-05-27 | Techlab Inc | Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker |
EP2087908B1 (en) | 2001-06-26 | 2018-05-30 | Amgen Inc. | Antibodies to opgl |
JP2005508495A (ja) | 2001-09-06 | 2005-03-31 | ジェノミック プロファイリング システムズ インコーポレイティッド | 分子の迅速かつ高感度の検出法 |
EP1300472A1 (en) | 2001-10-02 | 2003-04-09 | Stichting Top-Instituut Voedselwetenschappen | A method for testing the effect of nutrients on gastrointestinal colonisation resistance of humans |
GB0124580D0 (en) | 2001-10-12 | 2001-12-05 | Univ Reading | New composition |
WO2003050533A1 (en) | 2001-12-10 | 2003-06-19 | Ardais Corporation | Systems and methods for obtaining data correlated patient samples |
US20030161871A1 (en) | 2001-12-19 | 2003-08-28 | Geoffrey Hird | Solubilized riboflavin |
AUPS088702A0 (en) | 2002-03-04 | 2002-03-28 | Borody, Thomas Julius | Electrolyte purgative |
US20040265291A1 (en) | 2003-01-24 | 2004-12-30 | Flora Technology Inc. | Compositions and methods for restoring bacterial flora |
GB0322791D0 (en) | 2003-09-30 | 2003-10-29 | Lifeforce Group Plc | Blood co-processing for contingent autologous leukocyte transplantation |
US20050239706A1 (en) | 2003-10-31 | 2005-10-27 | Washington University In St. Louis | Modulation of fiaf and the gastrointestinal microbiota as a means to control energy storage in a subject |
US20060008511A1 (en) | 2004-07-08 | 2006-01-12 | Jhy-Jhu Lin | Probiotic products for pet applications |
US7935334B2 (en) | 2005-07-07 | 2011-05-03 | Imagilin Technologies, LLC | Probiotics as alternative medicines against infectious diseases |
US7909806B2 (en) * | 2004-09-23 | 2011-03-22 | Anthrogenesis Corporation | Cord blood and placenta collection kit |
EP1817432A2 (en) | 2004-10-05 | 2007-08-15 | Wyeth a Corporation of the State of Delaware | Probe arrays for detecting multiple strains of different species |
US20080269258A1 (en) | 2004-11-08 | 2008-10-30 | Breaker Ronald R | Riboswitches, Structure-Based Compound Design with Riboswitches, and Methods and Compositions for Use of and with Riboswitches |
US20060276769A1 (en) * | 2004-12-23 | 2006-12-07 | John Domkowski | Medical fluid container |
US20060210448A1 (en) | 2005-03-10 | 2006-09-21 | Naishu Wang | Fecal specimen collection, preserving and transport device and method |
US7607776B1 (en) | 2005-10-24 | 2009-10-27 | James Waller Lambuth Lewis | Digital eye bank for virtual clinic trials |
EP1974052A2 (en) | 2005-12-21 | 2008-10-01 | Yale University | Methods and compositions related to the modulation of riboswitches |
CN101351124B (zh) | 2005-12-29 | 2014-09-03 | 希尔氏宠物营养品公司 | 用于改变动物的肠道菌群的方法 |
US20080027353A1 (en) | 2006-07-31 | 2008-01-31 | Kliman Harvey J | Method of making and using a library of biological information |
RU2009117828A (ru) * | 2006-10-13 | 2010-11-20 | Релайанс Лайф Сайенсиз Пвт. Лтд. (In) | Культивированные меланоциты на биополимерах |
EP2102350A4 (en) | 2006-12-18 | 2012-08-08 | Univ St Louis | INTESTINAL MICROBIOMA AS A BIOMARKER AND THERAPEUTIC TARGET FOR TREATING OBESITY OR OBESITY-RELATED DISORDER |
CN100519738C (zh) | 2007-02-02 | 2009-07-29 | 丽珠医药集团股份有限公司 | 一种双歧杆菌活菌制剂及其专用保护剂 |
EP2030623A1 (en) | 2007-08-17 | 2009-03-04 | Nestec S.A. | Preventing and/or treating metabolic disorders by modulating the amount of enterobacteria |
WO2009042642A2 (en) * | 2007-09-24 | 2009-04-02 | President And Fellows Of Harvard College | Compositions and methods for the treatment and prevention of ulcerative colitis and colon cancer |
US20090148540A1 (en) | 2007-12-10 | 2009-06-11 | Mi Hope Incorporated | Antibacterial composition and method of production |
US20110237549A1 (en) | 2008-03-27 | 2011-09-29 | Memorial Sloan Kettering Cancer Center | Modulators of rna riboswitches |
US20110177976A1 (en) | 2008-06-30 | 2011-07-21 | The Washington University | Methods for promoting weight loss and associated arrays |
US20100008850A1 (en) | 2008-07-14 | 2010-01-14 | William John Martin | Method of generating hydrogen in drinking water using an enerceutical product added to magnesium in a hydrogen permeable but solute impermeable container |
MX2011000498A (es) | 2008-07-17 | 2011-06-21 | Bioworks Inc | Control de enfermedades de plantas e incremento del crecimiento de plantas usando una combinacion de una especie de trichoderma virens y una especie de trichoderma harzianum competente de rizosfera. |
MX2011001679A (es) | 2008-08-11 | 2011-12-16 | Biorelix Inc | Derivados de flavina. |
JP5525280B2 (ja) * | 2009-02-19 | 2014-06-18 | 裕昭 乾 | 細胞をガラス化保存する方法および細胞のガラス化保存用容器 |
GB0916335D0 (en) | 2009-09-17 | 2009-10-28 | Martin W J | Medicaments |
PL2480255T3 (pl) | 2009-09-23 | 2018-07-31 | Thomas Julius Borody | Terapia przewlekłych zakażeń jelitowych |
DE112010004110T8 (de) | 2009-10-22 | 2012-12-06 | Thomas Julius Borody | Neue parasitentherapie |
AU2010312309B2 (en) | 2009-10-26 | 2016-10-06 | Thomas Julius Borody | Novel enteric combination therapy |
HRP20220751T1 (hr) | 2010-02-01 | 2022-09-02 | Rebiotix, Inc. | Bakterioterapija clostridium difficile kolitisa |
US8853269B2 (en) | 2010-02-04 | 2014-10-07 | Copperhead Chemical Company Inc. | Composition and method for treating infections and promoting intestinal health |
FI20105478A0 (fi) | 2010-04-30 | 2010-04-30 | Valtion Teknillinen | Menetelmä tyypin 1 diabeteksen diagnosoimiseksi ja menetelmiä ja koostumuksia tyypin 1 diabeteksen puhkeamisen estämiseksi |
US9707207B2 (en) | 2010-05-26 | 2017-07-18 | The United States Of America As Represented By The Department Of Veterans Affairs | Method for diagnosing, preventing, and treating neurological diseases |
WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性t細胞の増殖または集積を誘導する作用を有する組成物 |
FI20105825A (fi) | 2010-07-26 | 2012-01-27 | Suomen Punainen Risti Veripalvelu | Veriryhmästatuksen käyttö III |
EP2598155A2 (en) | 2010-07-26 | 2013-06-05 | Suomen Punainen Risti Veripalvelu | Use of blood group status iii |
SG187713A1 (en) * | 2010-08-04 | 2013-03-28 | Borody Thomas J | Compositions for fecal floral transplantation and methods for making and using them and devices for delivering them |
WO2012024638A2 (en) | 2010-08-20 | 2012-02-23 | New York University | Compositions and methods for treating obesity and related disorders by characterizing and restoring mammalian bacterial microbiota |
EP2613802A4 (en) | 2010-09-10 | 2014-03-26 | Viropharma Inc | ENVIRONMENTAL CLOSTRIDAL BACTERIOTHERAPY AND ASSOCIATED FORMULATIONS AND METHODS OF MAKING AND USING SAME |
WO2014152484A1 (en) * | 2013-03-14 | 2014-09-25 | Regents Of The University Of Minnesota | Freeze dried fecal microbiota for use in fecal microbial transplantation |
WO2012122522A2 (en) | 2011-03-09 | 2012-09-13 | Washington University | Cultured collection of gut microbial community |
ES2636439T3 (es) * | 2011-03-09 | 2017-10-05 | Regents Of The University Of Minnesota | Composiciones y métodos para el trasplante de microbiota de colon |
WO2012142605A1 (en) | 2011-04-15 | 2012-10-18 | Samaritan Health Services | Rapid recolonization deployment agent |
US20120276059A1 (en) | 2011-04-29 | 2012-11-01 | Techlab, Inc. | Fecal lactoferrin as a biomarker for determining disease severity and for monitoring infection in patients with clostridium difficile disease |
US20130022575A1 (en) | 2011-07-19 | 2013-01-24 | Microbial Rx | Systems and methods of replacing intestinal flora |
WO2013032538A1 (en) | 2011-08-26 | 2013-03-07 | Microbiota Diagnostics, Llc | Methods for diagnosing and treating cardiac defects |
CN103857402A (zh) | 2011-10-11 | 2014-06-11 | 阿基姆医药公司 | 包括厌氧培养的人类肠道微生物群的组合物 |
WO2013090825A1 (en) | 2011-12-15 | 2013-06-20 | Pureflora, Inc. | Device for the collection, refinement, and administration of gastrointestinal microflora |
EP2636684A1 (en) | 2012-03-09 | 2013-09-11 | CSL Behring AG | Prevention of infection |
US9421233B2 (en) | 2012-04-27 | 2016-08-23 | Cedars-Sinai Medical Center | Fungal mycobiome as probiotics, diagnostics and therapeutics |
DK2850202T3 (da) | 2012-05-18 | 2020-05-18 | Genome Res Ltd | Fremgangsmåder og grupper |
US8906668B2 (en) | 2012-11-23 | 2014-12-09 | Seres Health, Inc. | Synergistic bacterial compositions and methods of production and use thereof |
NZ709392A (en) | 2012-11-23 | 2016-10-28 | Seres Therapeutics Inc | Synergistic bacterial compositions and methods of production and use thereof |
BR112015012123A8 (pt) | 2012-11-26 | 2018-01-23 | Borody Thomas J | composições para a recuperação de uma microbiota fecal e métodos para produzir e usar as mesmas. |
KR102164364B1 (ko) * | 2012-12-23 | 2020-10-12 | 일루미네이트 컨설팅, 엘엘씨. | 온도에 민감한 제품의 열 보호 및/또는 운송 방법 및 장치 |
EP3904502A3 (en) | 2013-02-04 | 2022-02-23 | Seres Therapeutics, Inc. | Compositions and methods |
BR112015018625A2 (pt) | 2013-02-04 | 2017-09-19 | Seres Therapeutics Inc | composições e métodos |
US9192361B2 (en) | 2013-02-26 | 2015-11-24 | Christopher J Stevens | Fecal microbiome transplant material preparation method and apparatus |
US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
CA2914636C (en) | 2013-06-05 | 2021-04-06 | Rebiotix, Inc. | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
DK3297644T3 (da) | 2015-05-22 | 2022-04-11 | Univ Arizona State | Fremgangsmåder til behandling af autismespektrumforstyrrelse og forbundne symptomer |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
IL281424B2 (en) | 2015-06-09 | 2023-10-01 | Rebiotix Inc | Microbiota restoration treatment preparations and production methods |
US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
-
2014
- 2014-06-04 CA CA2914636A patent/CA2914636C/en active Active
- 2014-06-04 CN CN202111357079.XA patent/CN114099553A/zh active Pending
- 2014-06-04 KR KR1020207007721A patent/KR102291174B1/ko active IP Right Grant
- 2014-06-04 ES ES14742388.3T patent/ES2673581T3/es active Active
- 2014-06-04 EP EP18170305.9A patent/EP3375447A1/en active Pending
- 2014-06-04 EP EP14742388.3A patent/EP3003330B1/en not_active Revoked
- 2014-06-04 DK DK14742388.3T patent/DK3003330T3/en active
- 2014-06-04 EP EP23172424.6A patent/EP4234011A3/en active Pending
- 2014-06-04 PL PL14742388T patent/PL3003330T3/pl unknown
- 2014-06-04 CN CN201480044316.9A patent/CN105473152A/zh active Pending
- 2014-06-04 KR KR1020167000098A patent/KR102093537B1/ko active IP Right Grant
- 2014-06-04 JP JP2016517952A patent/JP6330032B2/ja active Active
- 2014-06-04 WO PCT/US2014/040856 patent/WO2014197562A1/en active Application Filing
- 2014-06-04 LT LTEP14742388.3T patent/LT3003330T/lt unknown
- 2014-06-04 AU AU2014275025A patent/AU2014275025B2/en active Active
- 2014-06-04 PT PT14742388T patent/PT3003330T/pt unknown
- 2014-06-04 US US14/295,686 patent/US9675648B2/en active Active
- 2014-06-04 KR KR1020177037164A patent/KR102099503B1/ko active IP Right Grant
- 2014-06-04 HU HUE14742388A patent/HUE040211T2/hu unknown
- 2014-06-04 SI SI201430828T patent/SI3003330T1/sl unknown
- 2014-06-30 US US14/319,852 patent/US9433651B2/en active Active
- 2014-08-15 US US14/461,027 patent/US20140363400A1/en not_active Abandoned
-
2015
- 2015-04-17 US US14/689,464 patent/US10603341B2/en active Active
- 2015-11-12 US US14/939,669 patent/US9642880B2/en active Active
- 2015-12-03 IL IL242934A patent/IL242934B/en active IP Right Grant
-
2016
- 2016-08-17 US US15/239,287 patent/US10610547B2/en active Active
-
2017
- 2017-02-27 AU AU2017201330A patent/AU2017201330B2/en active Active
- 2017-05-10 US US15/591,758 patent/US10391129B2/en active Active
- 2017-06-07 JP JP2017112144A patent/JP6363259B2/ja active Active
- 2017-06-09 US US15/618,718 patent/US10624932B2/en active Active
- 2017-06-16 US US15/625,715 patent/US10471107B2/en active Active
- 2017-06-22 US US15/630,234 patent/US10493111B2/en active Active
-
2018
- 2018-08-09 HR HRP20181302TT patent/HRP20181302T1/hr unknown
- 2018-08-23 AU AU2018220114A patent/AU2018220114B2/en active Active
- 2018-11-21 IL IL263175A patent/IL263175B/en active IP Right Grant
-
2020
- 2020-04-07 US US16/841,791 patent/US11554143B2/en active Active
- 2020-04-22 AU AU2020202691A patent/AU2020202691B2/en active Active
-
2022
- 2022-06-22 AU AU2022204369A patent/AU2022204369A1/en active Pending
- 2022-12-07 US US18/062,934 patent/US20230210912A1/en active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL263175B (en) | Microbiota restoration therapy (mrt) compounds and methods of manufacture | |
IL281424A (en) | Microbiota restoration treatment preparations and production methods | |
IL254016A0 (en) | A preparation for medical and preventive treatment produced by microbiota | |
EP2991946A4 (en) | Pumice-containing remedial compositions and methods of use | |
IL286759A (en) | Therapeutic methods and preparations | |
EP2836224A4 (en) | COMPOSITIONS OF BIOZOOSE AND RELATED METHODS | |
EP3038646A4 (en) | Diagnostic methods and compositions for treatment of glioblastoma | |
GB201320723D0 (en) | Composition and methods of treatment | |
EP3035933A4 (en) | Compositions and therapeutic methods for accelerated plaque regression | |
EP3021839A4 (en) | Methods and compositions for treatment of fibrosis | |
IL239840A0 (en) | Polymyxins, preparations, methods of preparation and methods of use | |
EP3035934A4 (en) | Compositions and therapeutic methods for accelerated plaque regression | |
PL2988764T3 (pl) | Kompozycje przeciwłupieżowe i sposoby ich zastosowania | |
HK1220374A1 (zh) | 用於治療碳氧血紅蛋白血症的組合物和方法 | |
EP3071214A4 (en) | Salacia compositions, methods of treatment by their administration, and methods of their preparation | |
EP3080246A4 (en) | Compositions and methods for producing and administering brown adipocytes | |
EP3057596A4 (en) | Compositions and methods of administering same | |
EP2994147A4 (en) | Compositions and methods for the treatment of tinnitus | |
IL244537A0 (en) | New administration preparations and methods of their use | |
EP3016981A4 (en) | Compositions and methods for treatment of stroke | |
EP2988737A4 (en) | Methods and compositions for treating diseases | |
AU2013903955A0 (en) | Compositions and Methods of Administering Same | |
AU2013902004A0 (en) | Compositions for Therapy and Methods of Treatment | |
AU2013901658A0 (en) | Compositions and methods for the treatment of tinnitus | |
AU2013904774A0 (en) | Methods and Preparation and Use of Xanthorrhoeaceae Compositions |